China
· Delayed Price · Currency is CNY Zhejiang Huahai Pharmaceutical Statistics
Total Valuation
Zhejiang Huahai Pharmaceutical has a market cap or net worth of CNY 23.76 billion. The enterprise value is 29.17 billion.
| Market Cap | 23.76B |
| Enterprise Value | 29.17B |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | Jul 10, 2024 |
Share Statistics
Zhejiang Huahai Pharmaceutical has 1.45 billion shares outstanding. The number of shares has decreased by -1.10% in one year.
| Shares Outstanding | 1.45B |
| Shares Change (YoY) | -1.10% |
| Shares Change (QoQ) | +3.38% |
| Owned by Insiders (%) | 42.03% |
| Owned by Institutions (%) | 12.34% |
| Float | 840.01M |
Valuation Ratios
The trailing PE ratio is 23.45 and the forward PE ratio is 15.62.
| PE Ratio | 23.45 |
| Forward PE | 15.62 |
| PS Ratio | 2.59 |
| PB Ratio | 2.78 |
| P/FCF Ratio | 20.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.15, with an EV/FCF ratio of 24.86.
| EV / Earnings | 28.88 |
| EV / Sales | 3.19 |
| EV / EBITDA | 12.15 |
| EV / EBIT | 18.41 |
| EV / FCF | 24.86 |
Financial Position
The company has a current ratio of 1.42, with a Debt / Equity ratio of 76.97.
| Current Ratio | 1.42 |
| Quick Ratio | 0.81 |
| Debt / Equity | 76.97 |
| Debt / EBITDA | 2.87 |
| Debt / FCF | 5.88 |
| Interest Coverage | 7.17 |
Financial Efficiency
Return on equity (ROE) is 11.58% and return on invested capital (ROIC) is 6.19%.
| Return on Equity (ROE) | 11.58% |
| Return on Assets (ROA) | 5.07% |
| Return on Capital (ROIC) | 6.19% |
| Revenue Per Employee | 1.11M |
| Profits Per Employee | 122,882 |
| Employee Count | 8,221 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -2.56% in the last 52 weeks. The beta is 0.08, so Zhejiang Huahai Pharmaceutical's price volatility has been lower than the market average.
| Beta (5Y) | 0.08 |
| 52-Week Price Change | -2.56% |
| 50-Day Moving Average | 17.21 |
| 200-Day Moving Average | 15.56 |
| Relative Strength Index (RSI) | 38.95 |
| Average Volume (20 Days) | 8,482,878 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zhejiang Huahai Pharmaceutical had revenue of CNY 9.14 billion and earned 1.01 billion in profits. Earnings per share was 0.70.
| Revenue | 9.14B |
| Gross Profit | 5.51B |
| Operating Income | 1.58B |
| Pretax Income | 1.37B |
| Net Income | 1.01B |
| EBITDA | 2.38B |
| EBIT | 1.58B |
| Earnings Per Share (EPS) | 0.70 |
Balance Sheet
The company has 1.66 billion in cash and 6.90 billion in debt, giving a net cash position of -5.24 billion or -3.62 per share.
| Cash & Cash Equivalents | 1.66B |
| Total Debt | 6.90B |
| Net Cash | -5.24B |
| Net Cash Per Share | -3.62 |
| Equity (Book Value) | 8.96B |
| Book Value Per Share | 5.91 |
| Working Capital | 2.41B |
Cash Flow
In the last 12 months, operating cash flow was 2.62 billion and capital expenditures -1.45 billion, giving a free cash flow of 1.17 billion.
| Operating Cash Flow | 2.62B |
| Capital Expenditures | -1.45B |
| Free Cash Flow | 1.17B |
| FCF Per Share | 0.81 |
Margins
Gross margin is 60.24%, with operating and profit margins of 17.33% and 11.05%.
| Gross Margin | 60.24% |
| Operating Margin | 17.33% |
| Pretax Margin | 15.00% |
| Profit Margin | 11.05% |
| EBITDA Margin | 26.06% |
| EBIT Margin | 17.33% |
| FCF Margin | 12.84% |
Dividends & Yields
This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.22%.
| Dividend Per Share | 0.20 |
| Dividend Yield | 1.22% |
| Dividend Growth (YoY) | -16.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 32.52% |
| Buyback Yield | 1.10% |
| Shareholder Yield | 2.32% |
| Earnings Yield | 4.26% |
| FCF Yield | 4.94% |
Stock Splits
The last stock split was on June 8, 2020. It was a forward split with a ratio of 1.1.
| Last Split Date | Jun 8, 2020 |
| Split Type | Forward |
| Split Ratio | 1.1 |